Followers | 48 |
Posts | 1181 |
Boards Moderated | 0 |
Alias Born | 04/20/2018 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 12, 2019 10:14:12 AM
I have been a staunch advocate of CMTH/CELZ since last May, given patience and time for them to do what they need to do to grow the business and supported them with a large investment of my money.
However, with the ceaseless shares hitting the market for 8 months and our SP trying to cling to a penny, I think it's only fair and reasonable to expect a little more transparency from CMTH/CELZ leadership. They don't need to give away confidential info; however, they need to be clear and direct with shareholders. There is a lack of trust and it's reflected in the SP!
I have made my views clear to Don Dickerson and Tim Warbington over the past 6 months. However, unless more shareholders with positions reach out to leadership and request a shareholder call or some direct understanding of where things stand in relation to past PR's issued, nothing will change.
For example, what happened to Barton Wachs of Orange County and Sheldon Freedman of Las Vegas who were announced as a CaverStem doctors last year and were on the old website but not the new/improved CaverStem website list of doctors? Did anyone get a PR on what happened to them?
What is transpiring with Switzerland and Alto Uro? We received an 8k 6+ months ago about them coming online in Oct/Nov and have not received any news since. What about Russia? Where do things stand? What are the objectives for Europe and Int'l. Is Gershman still the guy heading it up as we've received no info on what he's working to accomplish.
WE the shareholders deserve better! I have over $100k invested in this company, have been a huge supporter in CMTH/CELZ and their approach to treating human conditions; however, I've been in business long enough and a shareholder in small and large companies long enough, to know when things are on track and when improvement is needed.
It is time CELZ leadership earn OUR trust which has declined. I would suggest we either write as a group of shareholders or you do so individually as I have, but make yourself heard. The board is NOT the place to make CHANGE happen. It is for sharing ideas and info.
I will continue to hold my shares and let things progress; however, I would highly recommend that long shareholders ban together and request a call with CELZ leadership or some clarity on the questions I raise above and others so that trust is built. Then the SP will adjust to it's true home which is much higher than it is now. Or it will erode slowly down.
Enjoy the day.
CF
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM